logo
Select company
Select metric
$ 32.42MNet Cash Flow - Investing
VS
Market
89
Sector
86
Industry
80
History
71
$ 0.37Close
$ 0.29 - $ 4.28 52-Week Range
Ticker Information

Ticker

VYNE

Company Name

VYNE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VYNE THERAPEUTICS INC - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VYNE - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ 32.42M
3/31/2025$ 46.77M
12/31/2024$ 23.36M
9/30/2024$ -51.73M
6/30/2024$ -46.9M
3/31/2024$ -65.92M
12/31/2023$ -57.35M
9/30/2023$ 4.07M
6/30/2023$ 3.98M
3/31/2023$ 3.98M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VYNE THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Investing stands at $ 100.18M.
  • Over the past 5 years, VYNE THERAPEUTICS INC's average CF - Investing has been $ 8.94M.
  • The median CF - Investing for VYNE THERAPEUTICS INC during this period was $ 9.87M
  • VYNE THERAPEUTICS INC reached its highest CF - Investing over the past 5 years at $ 100.18M.
  • The lowest CF - Investing recorded by VYNE THERAPEUTICS INC in the same timeframe $ -65.92M

VYNE THERAPEUTICS INC's CF - Investing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investing Benchmarks
CompanyCF - Investing
ERNA : ERNEXA THERAPEUTICS INC $ -19KBRTX : BIORESTORATIVE THERAPIES INC $ 6.97MHCWB : HCW BIOLOGICS INC $ -150.47KLYRA : LYRA THERAPEUTICS INC $ 36.27MAPRE : APREA THERAPEUTICS INC $ 0AIM : AIM IMMUNOTECH INC $ 5.69MIBIO : IBIO INC $ 742KADIL : ADIAL PHARMACEUTICALS INC $ 150KCELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ -200KDWTX : DOGWOOD THERAPEUTICS INC $ 0

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

VYNE - Net Cash Flow - Investing, Last 5 years

$ -65.92M

Minimum

Mar 31, 2024

$ 100.18M

Maximum

Sep 30, 2020

$ 8.94M

Average

$ 9.87M

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.34M with a standard deviation of $ 83.4M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.16K
min$ -292.23M
max$ 241M
average$ -35.34M
median$ -6.39M
std$ 83.4M